5-Aminosalicylic Acid Distribution into the Intestinal Membrane Along the Gastrointestinal Tract After Oral Administration in Rats
Open Access
- 7 December 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (12) , 1567
Abstract
Background: 5-Aminosalicylic acid (5-ASA), the first-line therapy for ulcerative colitis, is a poorly soluble zwitterionic drug. Unformulated 5-ASA is thought to be extensively absorbed in the small intestine. Methods: The pH-dependent solubility of 5-ASA in vitro and the intestinal membrane distribution of 5-ASA and its N-acetyl metabolite (AC-5-ASA) after the oral administration of 5-ASA were examined in fed rats. 5-ASA was administered as a suspension in water, 0.1 M HCl, or 0.1 M NaOH to untreated rats or as a solution in 5% NaHCO3 to lansoprazole-pretreated rats. Results: 5-ASA solubility in vitro was higher at pH < 2 and pH > 7. In rats, the 5-ASA and AC-5-ASA were detected mostly in the small intestine at 3 h and in the colonic region at 8 h after administration. The dosing vehicle (suspension or solution) and lansoprazole pretreatment did not significantly affect the pH of the luminal fluid in rats or the 5-ASA distribution in membranes. Conclusions: The 5-ASA distribution in membranes in the proximal intestine was found to be restricted by the intrinsic regional luminal pH, low solubility, and saturable membrane permeability. Unabsorbed 5-ASA in the proximal intestine was delivered to the distal intestine. The higher the oral dose of 5-ASA, the more 5-ASA may be delivered to the distal intestine due to the restricted absorption in the small intestine.Keywords
This publication has 44 references indexed in Scilit:
- Downregulation of OATP2B1 by proinflammatory cytokines leads to 5-ASA hyposensitivity in Ulcerative colitisChemico-Biological Interactions, 2024
- Population pharmacokinetics and IVIVC for mesalazine enteric-coated tabletsJournal of Controlled Release, 2022
- Interindividual and intraindividual variability of fasted state gastric fluid volume and gastric emptying of waterEuropean Journal of Pharmaceutics and Biopharmaceutics, 2018
- Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable DrugsMolecular Pharmaceutics, 2017
- Magnetic Resonance Imaging Quantification of Fasted State Colonic Liquid Pockets in Healthy HumansMolecular Pharmaceutics, 2017
- Evaluation of Dissolution in the Lower Intestine and Its Impact on the Absorption Process of High Dose Low Solubility DrugsMolecular Pharmaceutics, 2017
- Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal TractMolecular Pharmaceutics, 2016
- Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: A real-life survey in SpainJournal of Crohn's and Colitis, 2010
- Transport studies with 5-aminosalicylateEuropean Journal of Clinical Pharmacology, 2006
- High-performance liquid chromatographic assay for the determination of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid concentrations in endoscopic intestinal biopsy in humansJournal of Chromatography B: Biomedical Sciences and Applications, 1991